A substantial fraction of neuroblastomas found by mass screening have been
suggested to regress spontaneously because of the high incidence of infanti
le neuroblastomas in the screening population. In this study, 70 neuroblast
omas were analyzed for expression of proto-oncogenes related to neuronal di
fferentiation to clarify the biological significance of proto-oncogene expr
ession in the screening-positive and -negative tumors. The tumors consisted
of 39 neuroblastomas found by screening (group 1), 16 non-N-myc-amplified
nenroblastomas found by clinical symptom(s) (group 2), and 15 N-myc-amplifi
ed neuroblastomas found by clinical symptom(s) (group 3), The expression of
c-spc, trk A, and N-myc in tumor tissues was analyzed by quantitative RNA
PCR, Neuronal c-srcN2 expression varied significantly in the following orde
r: group 1 > group 2 > group 3, The level of expression of trk A was marked
ly reduced in group 3 but did not differ in groups 1 and 2, Most tumors in
group 3 overexpressed N-myc, However, N-myc expression in group 1 was signi
ficantly higher than that in group 2, Thus, the characteristics of proto-on
cogene expression in screening-positive tumors included enhanced expression
of c-srcN2 and N-myc mRNA, regardless of nonamplification of N-myc, Our re
sults suggest that the role of N-myc differs in neuroblastomas detected by
screening and in N-myc-amplified tumors.